| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/21/2001 | US6277584 Method for calibrating a chemical analyzer with improved accuracy at low signal levels |
| 08/21/2001 | US6277583 Affinity labeling libraries and applications thereof |
| 08/21/2001 | US6277582 Amplification and detection of mycoplasma pneumoniae targeting the P1 gene |
| 08/21/2001 | US6277574 Genes associated with diseases of the kidney |
| 08/21/2001 | US6277573 Detecting nucleic acid molecules and sequences for diagnosis of genetic disease or chromosomal abnormality, a predisposition to a disease, or infection by a pathogenic organism; high speed and accurate |
| 08/21/2001 | US6277566 Method for identifying a hedgehog-mediated phosphorylation state dependent transcription factor |
| 08/21/2001 | US6277565 OCT-3 gene encoding transporter-like molecules |
| 08/21/2001 | US6277564 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 08/21/2001 | US6277561 Isolation and characterization of retrovirus from the hiv group via hybridization of oligonucleotide to nucleic acid indicating the presence of immunodeficiency virus (mvp-5180/91) |
| 08/21/2001 | US6277559 Histamine measuring apparatus and a histamine measuring method |
| 08/21/2001 | US6277489 Support for high performance affinity chromatography and other uses |
| 08/21/2001 | US6277383 Ryegrass pollen allergen |
| 08/21/2001 | US6277379 Use of purified invaplex from gram negative bacteria as a vaccine |
| 08/21/2001 | US6277378 Inhibitory effect of synthetic and natural colorants on carcinogenesis |
| 08/21/2001 | US6277373 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase |
| 08/21/2001 | US6277329 Dissolved hydrogen analyzer |
| 08/21/2001 | US6277060 Centrifuge chamber for a cell separator having a spiral separation chamber |
| 08/21/2001 | US6277019 Method and apparatus for removing fat from meat cuts |
| 08/21/2001 | US6276873 Ground water remediation control process |
| 08/21/2001 | US6276536 Method of measuring ripeness and texture of vegetable or fruit and measuring instrument |
| 08/21/2001 | US6276222 Method for evaluating deterioration of insulating paper |
| 08/21/2001 | US6276209 System and method of assessing the structural properties of wooden members using ultrasound |
| 08/21/2001 | US6276192 Gas detecting sensor and device for controlling ventilation systems |
| 08/21/2001 | US6276190 Differential total-gas determination while drilling |
| 08/21/2001 | CA2299046A1 Method for rapid identification of wood species by laser induced plasma spectroscopy |
| 08/21/2001 | CA2073344C Fluorescence assay apparatus |
| 08/21/2001 | CA2025329C Characterizing matter of biological origin using near infrared spectroscopy |
| 08/21/2001 | CA2018751C Stable freeze dried polyhematoporphyrin ether/ester composition |
| 08/18/2001 | CA2299911A1 An automated method for rapidly performing multiple immunoassays by different membrane-eia test kit combinations in one operation |
| 08/17/2001 | CA2335773A1 A method of assessing the biological status of pathology in epithelial tissue |
| 08/17/2001 | CA2299210A1 A method of assessing the biological status of cancer development |
| 08/17/2001 | CA2299073A1 A method and apparatus for primary health diagnostics by performing comprehensive assays of urine sample day-to-day at home |
| 08/16/2001 | WO2001059683A2 Integrated genomic services |
| 08/16/2001 | WO2001059476A2 Sample preparation method |
| 08/16/2001 | WO2001059470A1 Method and apparatus for determining the lean content of meat products |
| 08/16/2001 | WO2001059463A1 Catalytic test device and method for the use thereof in material tests |
| 08/16/2001 | WO2001059462A1 Method of measuring lipid components and method of examining renal failure |
| 08/16/2001 | WO2001059461A2 Diagnosis or prediction of headache |
| 08/16/2001 | WO2001059460A2 Mapping of differential display of proteins |
| 08/16/2001 | WO2001059459A2 Compositions and methods for screening therapeutic agents |
| 08/16/2001 | WO2001059458A1 Specific monoclonal antibody against terbinafine |
| 08/16/2001 | WO2001059457A2 Assay for detection of viral fusion inhibitors |
| 08/16/2001 | WO2001059455A2 Immobilization of bioactive species |
| 08/16/2001 | WO2001059454A1 Method for detecting substance |
| 08/16/2001 | WO2001059453A2 Biosensor compositions and methods of use |
| 08/16/2001 | WO2001059452A2 Method for diagnosing efficacy of xenotypic antibody therapy |
| 08/16/2001 | WO2001059451A1 Enzyme-based gprotein-coupled receptor assay |
| 08/16/2001 | WO2001059450A2 Cells expressing zinc finger protein for drug discovery |
| 08/16/2001 | WO2001059449A1 Method and means of detecting elements in milk |
| 08/16/2001 | WO2001059448A1 Method of screening antiandrogen agent |
| 08/16/2001 | WO2001059447A1 Planar patch clamp electrodes |
| 08/16/2001 | WO2001059446A2 Assay for detecting change in membrane potential |
| 08/16/2001 | WO2001059442A1 Water-based water treatment method |
| 08/16/2001 | WO2001059433A1 Apparatus for determining contamination of working fluid |
| 08/16/2001 | WO2001059425A1 System, method and computer implemented process for assaying coagulation in fluid samples |
| 08/16/2001 | WO2001059163A2 Method for detecting and quantifying adenovirus |
| 08/16/2001 | WO2001059161A2 Analyte assays employing universal arrays |
| 08/16/2001 | WO2001059159A2 Molecular biological kit apparatus and method |
| 08/16/2001 | WO2001059158A1 Compositions and methods for the early diagnosis of ovarian cancer |
| 08/16/2001 | WO2001059157A2 Process for the enumeration and identification of microorganisms |
| 08/16/2001 | WO2001059156A2 DETECTION OF BINDING OF CHARGED SPECIES USING pH- OR POTENTIAL-SENSITIVE PROBES |
| 08/16/2001 | WO2001059155A2 Interferon-alpha induced genes |
| 08/16/2001 | WO2001059153A2 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels |
| 08/16/2001 | WO2001059152A2 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 08/16/2001 | WO2001059151A2 Method of designing and selecting polynucleotide sequences |
| 08/16/2001 | WO2001059150A1 Biomolecular toxicity assay |
| 08/16/2001 | WO2001059149A2 Peptide biosensors for anthrax protease |
| 08/16/2001 | WO2001059145A1 Regulated expression of plac in staphylococcus aureus |
| 08/16/2001 | WO2001059133A1 Larynx carcinoma-associated protein larcap-1 |
| 08/16/2001 | WO2001059130A2 Proteins producing an altered immunogenic response and methods of making and using the same |
| 08/16/2001 | WO2001059129A2 Mammalian secreted group iii phospholipase a2 |
| 08/16/2001 | WO2001059127A2 Drug metabolizing enzymes |
| 08/16/2001 | WO2001059120A2 Il-17 like molecules and uses thereof |
| 08/16/2001 | WO2001059114A2 Tumor suppressor gene, p47ing3 |
| 08/16/2001 | WO2001059110A2 34p3d7: a tissue specific protein highly expressed in prostate cancer |
| 08/16/2001 | WO2001059104A1 Partners of ptb1 domain of fe65, preparation and uses |
| 08/16/2001 | WO2001059103A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | WO2001059100A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | WO2001059096A1 Method of detecting ligand or ligand-like low-molecular weight compound |
| 08/16/2001 | WO2001059079A1 UDP-GALACTOSE: β-D-GALACTOSE-R 4-α-D-GALACTOSYLTRANSFERASE, α4GAL-T1 |
| 08/16/2001 | WO2001059073A2 Cytotoxic t lymphocytes activated by dendritic cell hybrids |
| 08/16/2001 | WO2001058959A1 Use of thrombin receptor antagonists against gliosis |
| 08/16/2001 | WO2001058958A1 Antibody binding superficial zone protein and their uses in diagnosis and screening methods |
| 08/16/2001 | WO2001058951A2 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/16/2001 | WO2001058947A1 Lipophilin complexes for use in cancer diagnosis and therapy |
| 08/16/2001 | WO2001058945A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | WO2001058944A1 Sodium-independent small neutral amino acid transporters transporting l- and d-amino acids and genes thereof |
| 08/16/2001 | WO2001058927A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 08/16/2001 | WO2001058926A2 Protein mapping |
| 08/16/2001 | WO2001058925A2 Protein separation and display |
| 08/16/2001 | WO2001058923A2 Improved systems for sensitive detection of g-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
| 08/16/2001 | WO2001058921A2 Methods and compositions for generating angiostatin |
| 08/16/2001 | WO2001058916A2 Antibodies to ccr5 |
| 08/16/2001 | WO2001058915A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/16/2001 | WO2001058810A1 Method and device for determining the evolution of a chemical reaction in a kiln and for adjusting the reaction |
| 08/16/2001 | WO2001058482A1 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 08/16/2001 | WO2001058476A2 Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity |
| 08/16/2001 | WO2001058461A1 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof |
| 08/16/2001 | WO2001058444A1 Use of cyp1b1 inhibitors for treating cancer |
| 08/16/2001 | WO2001058356A2 Method for determining absolute and effective blood viscosity |